These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 30717690

  • 1. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
    Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, Kriplani A.
    BMC Pregnancy Childbirth; 2019 Feb 04; 19(1):54. PubMed ID: 30717690
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
    Naqash A, Ara R, Bader GN.
    BMC Womens Health; 2018 Jan 05; 18(1):6. PubMed ID: 29304848
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.
    Shin HW, Go DY, Lee SW, Choi YJ, Ko EJ, You HS, Jang YK.
    Medicine (Baltimore); 2021 May 21; 100(20):e24571. PubMed ID: 34011020
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study.
    Lee S, Ryu KJ, Lee ES, Lee KH, Lee JJ, Kim T.
    J Obstet Gynaecol Res; 2019 Apr 21; 45(4):858-864. PubMed ID: 30932300
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R, Kriplani A, Mogili KD, Bhatla N, Kachhawa G, Saxena R.
    Int J Gynaecol Obstet; 2016 Apr 21; 133(1):43-8. PubMed ID: 26868063
    [Abstract] [Full Text] [Related]

  • 6. Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
    Gordon M, Sinopoulou V, Iheozor-Ejiofor Z, Iqbal T, Allen P, Hoque S, Engineer J, Akobeng AK.
    Cochrane Database Syst Rev; 2021 Jan 20; 1(1):CD013529. PubMed ID: 33471939
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.
    Bielesz B, Lorenz M, Monteforte R, Prikoszovich T, Gabriel M, Wolzt M, Gleiss A, Hörl WH, Sunder-Plassmann G.
    Clin J Am Soc Nephrol; 2021 Oct 20; 16(10):1512-1521. PubMed ID: 34470831
    [Abstract] [Full Text] [Related]

  • 8. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z, Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC.
    Semin Hematol; 2018 Oct 20; 55(4):223-234. PubMed ID: 30502851
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
    Basha A, Ibrahim MIM, Hamad A, Chandra P, Omar NE, Abdullah MAJ, Aldapt MB, Hussein RM, Mahfouz A, Adel AA, Shwaylia HM, Ekeibed Y, AbuMousa R, Yassin MA.
    PLoS One; 2021 Oct 20; 16(8):e0255104. PubMed ID: 34375369
    [Abstract] [Full Text] [Related]

  • 10. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study.
    Ikuta K, Hanashi H, Hirai K, Ota Y, Matsuyama Y, Shimura A, Terauchi M, Momoeda M.
    Int J Hematol; 2019 Jan 20; 109(1):41-49. PubMed ID: 30039442
    [Abstract] [Full Text] [Related]

  • 11. Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h.
    Touchard J, Perrin G, Berdot S, Pouchot J, Loustalot MC, Sabatier B.
    Eur J Clin Pharmacol; 2021 Feb 20; 77(2):189-195. PubMed ID: 32926203
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
    Onken JE, Bregman DB, Harrington RA, Morris D, Acs P, Akright B, Barish C, Bhaskar BS, Smith-Nguyen GN, Butcher A, Koch TA, Goodnough LT.
    Transfusion; 2014 Feb 20; 54(2):306-15. PubMed ID: 23772856
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana - An interventional study.
    Kant S, Kaur R, Ahamed F, Singh A, Malhotra S, Kumar R.
    Indian J Public Health; 2020 Feb 20; 64(2):168-172. PubMed ID: 32584300
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY, Kim MY, Kim YJ, Lee Y, Lee JJ, Jun JK, Shin JC, Cho YK, Lee KY, Kim A, Song TB.
    BMC Pregnancy Childbirth; 2018 Aug 28; 18(1):349. PubMed ID: 30153811
    [Abstract] [Full Text] [Related]

  • 15. Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Bertani L, Tricò D, Zanzi F, Baiano Svizzero G, Coppini F, de Bortoli N, Bellini M, Antonioli L, Blandizzi C, Marchi S.
    Nutrients; 2021 Feb 12; 13(2):. PubMed ID: 33673371
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
    Vanobberghen F, Lweno O, Kuemmerle A, Mwebi KD, Asilia P, Issa A, Simon B, Mswata S, Schmidlin S, Glass TR, Abdulla S, Daubenberger C, Tanner M, Meyer-Monard S.
    Lancet Glob Health; 2021 Feb 12; 9(2):e189-e198. PubMed ID: 33245866
    [Abstract] [Full Text] [Related]

  • 17. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J, FER-ASAP investigators.
    J Perinat Med; 2017 May 24; 45(4):443-453. PubMed ID: 27278921
    [Abstract] [Full Text] [Related]

  • 18. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec 24; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

  • 19. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB, Jaju PB.
    BMC Pregnancy Childbirth; 2017 May 08; 17(1):137. PubMed ID: 28482869
    [Abstract] [Full Text] [Related]

  • 20. Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients.
    Hofman JMG, Eisenga MF, Diepenbroek A, Nolte IM, van Dam B, Westerhuis R, Bakker SJL, Franssen CFM, Gaillard CAJM.
    BMC Nephrol; 2018 Sep 20; 19(1):242. PubMed ID: 30236065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.